| Basics |
|
Vaxart, Inc
|
| IPO Date: |
December 31, 1981 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.17 | 4.82%
|
| Avg Daily Range (30 D): |
$0.01 | 3.45%
|
| Avg Daily Range (90 D): |
$0.02 | 4.56%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.34M |
| Avg Daily Volume (30 D): |
.47M |
| Avg Daily Volume (90 D): |
.43M |
| Trade Size |
| Avg Trade Size (Sh.): |
281 |
| Avg Trade Size (Sh.) (30 D): |
1,509 |
| Avg Trade Size (Sh.) (90 D): |
1,242 |
| Institutional Trades |
| Total Inst.Trades: |
1,120 |
| Avg Inst. Trade: |
$1.61M |
| Avg Inst. Trade (30 D): |
$.66M |
| Avg Inst. Trade (90 D): |
$.66M |
| Avg Inst. Trade Volume: |
.28M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.86M |
| Avg Closing Trade (30 D): |
$1.31M |
| Avg Closing Trade (90 D): |
$1.31M |
| Avg Closing Volume: |
388.98K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.22
|
|
$-.07
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$ 148.2M
|
$
|
$ 20.88M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -50.7M
|
$
|
$ -15.59M
|
|
Operating Income / Loss
|
$ -48.84M
|
$
|
$ -14.94M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -5.16M
|
$
|
$ 3.47M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Feb 14, 2018:
1:11
|
|
Nov 09, 2012:
1:6
|
|
|
|